Medication advancement is the way toward carrying another pharmaceutical medication to the market once a lead compound has been recognized through the procedure of medication disclosure. It remembers preclinical research for microorganisms and creatures, petitioning for administrative status, for example, by means of the United States Food and Drug Administration for an investigational new medication to start clinical preliminaries on people, and may incorporate the progression of acquiring administrative endorsement with another medication application to advertise the medication.
Commentary: Pharmaceutical Regulatory Affairs: Open Access
Commentary: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Rapid Communication: Pharmaceutical Regulatory Affairs: Open Access
Rapid Communication: Pharmaceutical Regulatory Affairs: Open Access
Scientific Tracks Abstracts: Pharmacoeconomics: Open Access
Scientific Tracks Abstracts: Pharmacoeconomics: Open Access
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Posters-Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters-Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 